COMMUNIQUÉS West-GlobeNewswire

RadNet, Inc. to Present at the Bank of America Merrill Lynch 2017 Leveraged Finance Conference on November 29, 2017

22/11/2017 - 12:00

LOS ANGELES, Nov. 22, 2017 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]

Gemphire to Present at the Piper Jaffray and LD Micro Investor Conferences

22/11/2017 - 12:00

LIVONIA, Mich., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

22/11/2017 - 11:43

COPENHAGEN, Denmark, November 22, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company's share capital has been increased by nominally DKK 2,637,500 as a consequence of employees' exercise [...]

AroCell AB (publ) signs Letter of Intent with Korean-based company, Green Cross Cell Corporation.

22/11/2017 - 08:56

AroCell AB (publ) signs Letter of Intent with Korean-based company, Green Cross Cell Corporation. The companies have agreed to enter into a collaboration for the clinical development of TK 210 ELISA as a complementary [...]

AroCell AB: Reporting period 1 July - 30 September 2017

22/11/2017 - 08:46

AroCell AB (publ) Reporting period 1 July - 30 September 2017 Net sales were 0 (46) KSEK Losses after financial items were - 3,678 (- 2,590) KSEK Earnings per share were - 0.12 (- 0.09) SEK Cash flow from operating [...]

NEOVACS ANNONCE L'ATTRIBUTION GRATUITE DE BONS DE SOUSCRIPTION D'ACTIONS REMBOURSABLES AU BENEFICE DES ACTIONNAIRES DE LA SOCIETE ET UNE ÉMISSION OBLIGATAIRE CONVERTIBLE D'UN MONTANT DE 5,15 M€

22/11/2017 - 07:46

COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NEOVACS ANNONCE L'ATTRIBUTION GRATUITE DE BONS DE SOUSCRIPTION D'ACTIONS REMBOURSABLES (BSAR) AU BENEFICE DES ACTIONNAIRES DE LA SOCIETE ET LE [...]

Portola Pharmaceuticals Provides Update on Bevyxxa® (betrixaban) Commercial Launch

22/11/2017 - 00:22

SOUTH SAN FRANCISCO, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the [...]

Prima Secures European Patent Grant for Lead Product IMP321 in Cancer

22/11/2017 - 00:07

SYDNEY, Australia, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Prima BioMed Ltd (ASX:PRR) (NASDAQ: PBMD ) (“Prima”, the “Company”) announces the grant of patent number 2604275 entitled “Use of Recombinant LAG-3 or the Derivatives [...]

Synergy CHC Corp. Announces Third Quarter 2017 Results

21/11/2017 - 23:30

Westbrook, Maine, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, reported results for the quarter ended September 30, 2017. [...]

Celyad to Present at the 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 22:30

MONT-SAINT-GUIBERT, Belgium, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Euronext Paris:CYAD) (NASDAQ: CYAD ), a pioneer in the discovery and development of CAR-T cell therapies, today announced [...]

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 22:10

ROCKVILLE, Md., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq: SCMP ), a global biopharmaceutical company, today announced that it will participate in a fireside chat at the 29 th [...]

Assure Holdings Sets Third Quarter 2017 Conference Call for Thursday, November 30, 2017 at 5:00 p.m. ET

21/11/2017 - 22:05

PARKER, Colo., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV:IOM) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services, will hold a conference call on Thursday [...]

Ascendis Pharma A/S Announces Participation in Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference

21/11/2017 - 22:05

COPENHAGEN, Denmark, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare [...]

Tivity Health to Participate in The 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 22:05

NASHVILLE, Tenn., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ: TVTY ) will participate in The 29 th Annual Piper Jaffray Healthcare Conference to be held November 28 - 29, 2017, in New York City. [...]

Galapagos initiates Phase 1 study with novel CF corrector GLPG3221

21/11/2017 - 22:02

Triggers a $10 million milestone payment from AbbVie Sixth clinical candidate in cystic fibrosis portfolio Mechelen, Belgium; 21 November 2017; 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announces initiation [...]

Molecular Templates to Present at the 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 22:01

AUSTIN, Texas, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new [...]

Xtant Medical Reports Third Quarter 2017 Financial Results

21/11/2017 - 21:39

Company restructuring efforts continue to gain traction towards profitability Third Quarter 2017 Highlights Reported third quarter 2017 revenue of $19.8 million compared to $23.1 million reported during the third [...]

On the 20th anniversary of Canada’s tainted blood inquiry, documents reveal the federal government worked with private pharmaceutical industry to undermine Krever’s landmark recommendations

21/11/2017 - 21:30

OTTAWA, Nov. 21, 2017 (GLOBE NEWSWIRE) -- On the eve of the 20 th anniversary of the Krever Inquiry into the tainted blood scandal, parliamentarians, health advocates and health professionals gathered in Ottawa to call [...]

480 Biomedical’s Novel Technology Featured in Nature Materials

21/11/2017 - 19:30

WATERTOWN, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- 480 Biomedical, a clinical-stage life science company committed to transforming the lives of patients with chronic diseases, announced a publication in Nature [...]